Urethane-induced somatostatin mediated inhibition of gastric acid: Reversal by the somatostatin 2 receptor antagonist, PRL-2903

Life Sciences

Volumn 65, Issue 10, 1999, Pages PL115-PL120

  Kawakubo, Keishi ^a   Coy, David H ^b   Walsh, John H ^a   Taché, Yvette ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid secretion; PRL 2903; Somatostatin antibody; Somatostatin receptor antagonist

Indexed keywords

CELL SURFACE RECEPTOR; CURE S6; PRL 2903; SOMATOSTATIN; SOMATOSTATIN 2; SOMATOSTATIN 2 RECEPTOR ANTAGONIST; SOMATOSTATIN ANTIBODY; UNCLASSIFIED DRUG; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; ENZYME INDUCTION; GASTRIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STOMACH ACID; STOMACH ACID SECRETION;

ANIMALIA;

EID: 0033618492     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(99)00340-9     Document Type: Article

References (20)

1. G.M. Makhlouf and M.L. Schubert, Metabolism 39 138-142 (1990).
2. H. Yang, H. Wong, V. Wu, J.H. Walsh and Y. Taché, Gastroenterology 99 659-665 (1990).
3. G. Varga, I.J. Kisfalvi, K. Kordas, H. Wong, J.H. Walsh and T.E. Solomon, J. Physiol. Paris. 91 223-227 (1997).
4. Y.C. Patel, M. Greenwood, R. Panetta, N. Hukovic, S. Grigorakis, L.A. Robertson and C.B. Srikant, Metabolism 45 31-38 (1996).
5. D. Hoyer, G.I. Bell, M. Berelowitz, J. Epelbaum, W. Feniuk, P.P. Humphrey, A.M. O'Carroll, Y.C. Patel, A. Schonbrunn, J.E. Taylor, Trends.Pharmacol.Sci. 16 86-88 (1995)
6. C. Prinz, G. Sachs, J.H. Walsh, D.H. Coy and S.V. Wu, Gastroenterology 107 1067-1074 (1994).
7. K. Krempels, B. Hunyady, A.M. O'Carroll and E. Mezey, Gastroenterology 112 1948-1960 (1997).
8. W.J. Rossowski, Z.-F. Gu, U.S. Akarca, R.T. Jensen and D.H. Coy, Peptides 15 1421-1424 (1994).
9. K.C.K. Lloyd, J. Wang, K. Aurang, P. Grönhed, D.H. Coy and J.H. Walsh, Am. J. Physiol. 268 G102-G106 (1995).
10. M.A. Wyatt, E. Jarvie, W. Feniuk and P.P. Humphrey, Br. J. Pharmacol. 119 905-910 (1996)
11. K. Aurang, J. Wang and K.C. Lloyd, J. Pharmacol. Exp. Ther. 281 245-252 (1997).
12. V. Martinez, A. Curi, B. Torkian, J. Schaeffer, H.A. Wilkinson, J.H. Walsh and Y. Taché, Gastroenterology 114 1125-1132 (1998).
13. S.J. Hocart, R. Jain, W.A. Murphy, J.E. Taylor, B. Morgan and D.H. Coy, J. Med. Chem. 41 1146-1154 (1998).
14. W.R. Baumbach, T.A. Carrick, M.H. Pausch, B. Bingham, D. Carmignac, I.C. Robinson, R. Houghten, C.M. Eppler, L.A. Price and J.R. Zysk, Mol. Pharmacol. 54 864-873 (1998).
15. W.J. Rossowski, B.L. Cheng, N.Y. Jiang and D.H. Coy, Br. J. Pharmacol. 125 1081-1087 (1998).
16. H.C. Wong, J.H. Walsh, H. Yang, Y. Taché and A.M. Buchan, Peptides 11 707-712 (1990).
17. G.V. Ohning, H.C. Wong and J.H. Walsh, Peptides 15 417-423 (1994).
18. G. Sachs and C. Prinz, News Physiol. Sci. 11 57-62 (1996).
19. R. Hakanson, D. Chen, K. Andersson, H.J. Monstein, C.M. Zhao, B. Ryberg, F. Sundler and H. Mattsson, Yale J. Biol. Med. 67 123-134 (1994).
20. M. Zaki, L. Harrington, R. Mccuen, D.H. Coy, A. Arimura and M.L. Schubert, Gastroenterology 111 919-924 (1996).